ThETA

ThETA estimates the efficacy of gene-target–disease associations using RNA transcriptome data to support gene-based therapeutic target discovery.


Key Features:

  • Novel Efficacy Scoring Methods: Implements advanced efficacy scoring approaches that go beyond traditional log-fold change analysis to reduce false-positive associations.
  • Transcriptome-driven RNA Expression Analysis: Leverages RNA expression (transcriptome) data to drive efficacy estimates of gene perturbations.
  • Tissue-Specific Networks: Incorporates tissue-specific network information to evaluate gene perturbations and identify genes closely related to disease genes within specific tissues.
  • Integration of Efficacy Evaluations: Integrates efficacy evaluations derived from multiple methodologies into a composite overall efficacy score for gene-target–disease associations.
  • Visualization of Tissue Interconnections and Annotations: Provides visualization functions that illustrate tissue-specific interconnections between target and disease genes and highlight associated biological annotations.
  • R Implementation: Provided as an R package for computational analysis within the R environment.

Scientific Applications:

  • Drug discovery and development: Facilitates identification and prioritization of gene targets for therapeutic intervention based on transcriptome-derived efficacy estimates.
  • Target prioritization: Ranks gene-target–disease associations using integrated efficacy scores to support selection of high-confidence targets.
  • Reversal of disease expression patterns: Identifies gene perturbations that may reverse disease-gene expression signatures based on transcriptome comparisons.
  • Tissue-specific target identification: Enables discovery of targets with tissue-relevant relationships to disease genes using tissue-specific network analysis.

Methodology:

Uses a transcriptome-driven analysis of RNA expression data, computes efficacy scores that extend beyond log-fold change, incorporates tissue-specific networks, integrates multiple efficacy evaluation methods into an overall efficacy score, and accounts for statistical significance and biological context.

Topics

Details

License:
GPL-3.0
Programming Languages:
R
Added:
1/18/2021
Last Updated:
2/27/2021

Operations

Publications

Failli M, Paananen J, Fortino V. ThETA: transcriptome-driven efficacy estimates for gene-based TArget discovery. Bioinformatics. 2020;36(14):4214-4216. doi:10.1093/bioinformatics/btaa518. PMID:32437556. PMCID:PMC7390989.